MIT Sloan BioInnovations 2008

2004
2005
2006
2007
2008

MIT Sloan BioInnovations Conference Friday, April 18th, 2008

MIT Sloan School of Management
Kendall Square, Cambridge MA

Senior industry management, investors, and academics from the Massachusetts biotechnology community convene for a day of substantive idea exchange.

The Agenda

8:00	Registration and Morning Networking
9:00	Introduction of Morning Keynote
	Morning Keynote Speaker Christoph Westphal, MD, PhD Chief Executive Officer and Vice Chair, Sirtris Pharmaceuticals
10:00	Networking
10:30	Morning Panels Healthcare at Home: Revolutionizing the future of patient management through the adoption of home healthcare products. Panel Moderator Derek Wiebenson, R&D Manager, Baxter Healthcare Panel Participants Dan Lustgarten MD, PhD , Director, Cardiac Electrophysiology Research Laboratory, University of Vermont College of Medicine Douglas J. McClure, MIM, Corporate Manager - Technology and Operations, Center for Connected Health, Partners HealthCare Darrell Johnson,Vice President, Patient Management, Medtronic CRDM Gary Inglese, RN, MBA, Director U.S. Renal Reimbursement, Baxter Healthcare Social Entrepreneurship: An in-depth look at for-profit vs. non-profit models. Panel Moderator Mirena Bagur, Principal, CONTeXO Consulting Panel Participants Anita Goel, CEO, Nanobiosym Eugene Hill, Managing Partner, SV Life Sciences Vikram Kumar, Co-Founder, Chairman & Chief Medical Officer, Dimagi Inc. Peter Lomedico, PhD, Strategic Alliances, Juvenile Diabetes Research Foundation
11:30	Lunchtime Keynote Speaker Cris Ross, MBA Chief Information Officer, MinuteClinic
12:30	Lunch and BioEntreprensurship@MIT Showcase
2:00	Afternoon Panels R&D - Is Innovation Dead? What factors are determining the roadmap in R&D today? Panel Moderator Jonathan Reis, Extera Partners Panel Participants Charles Cooney, PhD, Professor of Chemical and Biochemical Engineering, MIT Douglas Hart, Professor of Mechanical Engineering, MIT, Founder, Brontes Technology Christine Brennan, PhD, Director of Strategic Alliances, Novartis Institute for Biomedical Research Jonathan J. Fleming, Managing General Partner, Oxford Bioscience Partners The First $10 Million - Going From Bench to Bedside: Exploring the pathways and pitfalls to commercialization. Panel Moderator Bob Buderi, CEO, Xconomy Panel Participants Michael Greeley, General Partner, Flybridge Capital Partners Janet Wolfe, PhD , CEO, Wolfe Laboratories Kurt Dasse, President & CEO, Levitronix LLC Nicho Hatsopoulos, PhD, Founder, Cyberkinetics, Principal Investigator, Hatsopoulos Lab at the University of Chicago
3:00	Networking
3:30	Closing Panel Is the World Ready for MyGenomeOnTheWeb.com? The implications of cheap, fast genomic data Panel Moderator Steve Dickman, CEO, CBT Advisors Panel Participants Jorge Conde, President and CEO, Knome Noubar Afeyan, PhD, Managing Partner and CEO, Flagship Ventures Dr. Mark Boguski, Founder, NIBR Integrated Program in Genome and Proteome Sciences Ron Ranauro, CEO, GenomeQuest Inc.